Celularity (CELU)
US Market

Celularity (CELU) Financial Statements


Celularity Financial Overview

Celularity's market cap is currently ―. The company's EPS TTM is $-0.487; its P/E ratio is -0.50; Celularity is scheduled to report earnings on November 10, 2023, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 1.28M$ 3.94M$ 4.13M$ 4.13M$ 3.78M
Gross Profit$ -82.47M$ 20.86M$ -1.12M$ -3.08M$ 597.00K
EBIT$ -47.95M$ -62.30M$ 28.19M$ 4.78M$ 47.84M
EBITDA$ -45.63M$ -61.76M$ 28.74M$ 7.18M$ 50.16M
Net Income Common Stockholders$ -47.95M$ -64.02M$ 24.43M$ 4.80M$ 47.83M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.08M$ 8.53M$ 13.97M$ 42.65M$ 38.00M
Total Assets$ 246.42M$ 362.42M$ 401.07M$ 437.12M$ 429.34M
Total Debt$ 61.95M$ 63.74M$ 65.59M$ 67.17M$ 27.85M
Net Debt$ 58.86M$ 55.21M$ 51.62M$ 24.52M$ -10.15M
Total Liabilities$ 127.92M$ 206.79M$ 202.16M$ 272.88M$ 279.19M
Stockholders Equity$ 118.50M$ 155.63M$ 198.90M$ 164.24M$ 150.15M
Cash Flow-
Free Cash Flow$ -11.06M$ -15.20M$ 95.91M$ -39.28M$ -37.76M
Operating Cash Flow$ -11.03M$ -14.99M$ 96.69M$ -37.72M$ -36.32M
Investing Cash Flow$ -31.00K$ -3.21M$ -127.06M$ -1.56M$ -1.44M
Financing Cash Flow$ 5.61M$ 12.76M$ 1.69M$ 43.94M$ 27.72M
Currency in USD

Celularity Earnings and Revenue History

Celularity Debt to Assets

Celularity Cash Flow

Celularity Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis